CRITERIA FOR TERMINATION OF PHASE-II CHEMOTHERAPY FOR PATIENTS WITH PROGRESSIVE OR RECURRENT BRAIN-TUMOR

被引：10

作者：

FRIEDMAN, HS

SCHOLD, SC

DJANG, WT

KURTZBERG, J

LONGEE, DC

HALPERIN, EC

FALLETTA, JM

COLEMAN, RE

OAKES, WJ

机构：

[1] DUKE UNIV,MED CTR,DEPT SURG,DURHAM,NC 27710

[2] DUKE UNIV,MED CTR,DEPT RADIOL,DURHAM,NC 27710

来源：

NEUROLOGY | 1989年 / 39卷 / 01期

关键词：

D O I：

10.1212/WNL.39.1.62

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

收藏

页码：62 / 66

页数：5

相关论文

共 6 条

[1] DICHIRO G, 1987, AM J NEURORADIOL, V8, P1083
[2] DICHIRO G, 1988, INVEST RADIOL, V5, P360
[3] DIFFERENTIATION OF CEREBRAL RADIATION NECROSIS FROM TUMOR RECURRENCE BY [F-18] FDG AND RB-82 POSITRON EMISSION TOMOGRAPHY
DOYLE, WK
BUDINGER, TF
VALK, PE
LEVIN, VA
GUTIN, PH
[J]. JOURNAL OF COMPUTER ASSISTED TOMOGRAPHY, 1987, 11 (04) : 563 - 570
[4] THE CHEMOTHERAPY OF POSTERIOR-FOSSA TUMORS IN CHILDHOOD
FRIEDMAN, HS
OAKES, WJ
[J]. JOURNAL OF NEURO-ONCOLOGY, 1987, 5 (03) : 217 - 229
[5] CHEMOTHERAPY OF PRIMARY BRAIN-TUMORS
LEVIN, VA
[J]. NEUROLOGIC CLINICS, 1985, 3 (04) : 855 - 866
[6] WITTES RE, 1985, CANCER TREAT REP, V69, P1235